Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing dose prediction software used to manage gentamicin dosing.

Internal medicine journal·2013
Same author

Carcinoma the colon; analysis of 113 cases.

The Southern surgeon·2010
Same author

Mtd/Bok takes a swing: proapoptotic Mtd/Bok regulates trophoblast cell proliferation during human placental development and in preeclampsia.

Cell death and differentiation·2009
Same author

Structures of three inhibitor complexes provide insight into the reaction mechanism of the human methylenetetrahydrofolate dehydrogenase/cyclohydrolase.

Biochemistry·2000
Same author

Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.

Journal of medicinal chemistry·1999
Same author

Histologic sectioning produces TUNEL reactivity. A potential cause of false-positive staining.

Archives of pathology & laboratory medicine·1999

Related Experiment Video

Updated: Jul 18, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Villous tumors: experience with 217 patients

P H Hanley, M O Hines, J E Ray

    The American Surgeon
    |April 1, 1971
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
    07:49

    Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

    Published on: April 13, 2015

    Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors
    03:37

    Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

    Published on: December 20, 2024

    Related Experiment Videos

    Last Updated: Jul 18, 2026

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
    07:49

    Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

    Published on: April 13, 2015

    Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors
    03:37

    Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors

    Published on: December 20, 2024